Compared with those in NP and BPH samples, the mRNA expression levels of Nav1.6 and Nav1.7 were dramatically upregulated in prostate cancer cells, suggesting these subtypes may be potential diagnostic markers for certain types of prostate cancer in humans. This evidence concerns the gene SCN9A and prostate carcinoma.